1. Home
  2. FTHY vs CRMD Comparison

FTHY vs CRMD Comparison

Compare FTHY & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Trust High Yield Opportunities 2027 Term Fund

FTHY

First Trust High Yield Opportunities 2027 Term Fund

N/A

Current Price

$13.51

Market Cap

496.4M

Sector

Finance

ML Signal

N/A

Logo CorMedix Inc.

CRMD

CorMedix Inc.

N/A

Current Price

$8.54

Market Cap

626.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FTHY
CRMD
Founded
2020
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
496.4M
626.0M
IPO Year
N/A
2009

Fundamental Metrics

Financial Performance
Metric
FTHY
CRMD
Price
$13.51
$8.54
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$14.83
AVG Volume (30 Days)
102.1K
1.2M
Earning Date
01-01-0001
05-11-2026
Dividend Yield
10.93%
N/A
EPS Growth
N/A
780.00
EPS
N/A
0.43
Revenue
N/A
$311,709,000.00
Revenue This Year
N/A
$0.30
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$19.98
Revenue Growth
N/A
617.03
52 Week Low
$13.20
$6.13
52 Week High
$14.98
$17.43

Technical Indicators

Market Signals
Indicator
FTHY
CRMD
Relative Strength Index (RSI) 51.78 57.01
Support Level $13.25 $8.09
Resistance Level $13.82 $8.94
Average True Range (ATR) 0.16 0.30
MACD 0.00 -0.00
Stochastic Oscillator 42.26 48.74

Price Performance

Historical Comparison
FTHY
CRMD

About FTHY First Trust High Yield Opportunities 2027 Term Fund

FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND is a diversified, closed-end management investment company. The investment objective of the fund is to provide current income. The fund invests a majority of its managed assets in high-yield debt securities of any maturity that are rated below investment grade at the time of purchase or unrated securities. Its investment portfolio comprises corporate bonds and notes, senior floating-rate loan interests, foreign corporate bonds and notes, money market funds, and other instruments across various industries.

About CRMD CorMedix Inc.

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

Share on Social Networks: